Health ❯Healthcare ❯Pharmaceuticals

Medications

GLP-1 Drugs GLP-1 Receptor Agonists Weight Loss Injections Alzheimer's Disease Weight Loss Tirzepatide GLP-1 Leucovorin Obesity and Diabetes Treatment Diabetes Metformin Presbyopia Treatment Finasteride Weight Loss Treatments Wegovy Weight-loss Injections Dementia Treatments GLP-1 Medicines Glifozine Topical Treatments Generic Medications GLP-1s Weight Loss Drugs Cyclobenzaprine Paxlovid Eye Drops Semaglutide Novo Nordisk GLP-1 Agonists Opioid Overdose Prevention GLP-1 Analogues Varenicline Blood Pressure Drugs

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

The move extends Novo Nordisk’s self-pay strategy to a major warehouse chain to channel patients toward authentic, FDA-approved pens.

Amgen Launches AmgenNow to Sell Repatha Direct to U.S. Patients at $239 a Month

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Prosecutors Confirm Paxlovid Exports to China as German Pharmacists Face Charges and Detention

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

Orforglipron Phase 3 Results Published, Show Promise as Oral GLP-1 Option for Obesity

Australian Study Finds Contraception Gaps and Pregnancies After GLP-1 Weight-Loss Prescriptions

Leqembi Launches in Germany for Early Alzheimer’s Patients

FDA Approves First New Fibromyalgia Treatment in 15 Years

EU Mandates New Warning on Systemic Diclofenac Skin Reaction

Survey Finds 95% of Mexicans Use Generics as Government Frees 386 Drug Patents

FDA Approves Vizz Eye Drops for Presbyopia

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

France to Let All Doctors Prescribe Wegovy and Mounjaro Starting June 23

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

New Studies Confirm Safety of Semaglutide for Mental Health